65 year old male with stage IVC salivary duct adenocarcinoma with a biopsy-proven solitary T7 spine metastasis treated with single fraction SBRT.
Technique:
Dose:
Chemotherapy: This patient’s salivary duct adenocarcinoma was androgen receptor positive, therefore he was initiated on androgen deprivation therapy prior to radiation.
Sim/Planning:
Case contributed by Mayo Clinic Rochester
Contours per International Spine Radiosurgery Consortium consensus guidelines.
Target Volume Definitions
OARs: Contour all OAR’s within 2 cm of the PTV_low.
A variety of dose and fraction schedules have been utilized in retrospective studies, single center prospective trials, and larger, cooperative group clinical trials. The most commonly utilized range of doses and fractionations are listed below. Selection of dose and fractionation may vary by metastatic location, size, tumor extent, and institutional practice patterns.
Dose Constraints:
Questions? Feedback? Report here